Let’s be clear from the start, Bruker never gets the spotlight afforded to much bigger life-science names, but the company has tech and research tools that give it a very defensible niche. The stock is often recognized by analysts but ignored by retail traders. It’s their loss, though.
There are no replies in this thread yet. Be the first to post a reply below: